PHAT · Categories · Form 4

PHAT - SEC Form 4 insider transactions

Phathom Pharmaceuticals Inc. (PHAT) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for PHAT

• 12d
  Director Parikh Asit received a gift of 28,000 shares and gifted 28,000 shares, decreasing direct ownership by 54% to 24,122 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 18d
  Director Parikh Asit was granted 24,122 shares and exercised 17,500 shares at a strike of $4.95, increasing direct ownership by 396% to 52,122 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 18d
  Director Fields Heidi was granted 24,122 shares, increasing direct ownership by 80% to 54,122 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 18d
  Director Topper James N was granted 24,122 shares, increasing direct ownership by 57% to 66,718 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 18d
  Director Stenhouse Mark was granted 24,122 shares, increasing direct ownership by 80% to 54,122 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 18d
  Director Schroeder Theodore R was granted 24,122 shares, increasing direct ownership by 115% to 45,122 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 18d
  Director Cola Michael F was granted 24,122 shares, increasing direct ownership by 61% to 63,920 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 18d
  Director Karbe Frank was granted 24,122 shares, increasing direct ownership by 36% to 91,622 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 89d
  SEC Form 4 filed by Phathom Pharmaceuticals Inc.

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 97d
  Principal Accounting Officer Breedlove Robert Charles was granted 15,790 shares and covered exercise/tax liability with 1,378 shares, increasing direct ownership by 31% to 61,480 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 116d
  Chief Legal Off. & Corp. Sec. Cook Anne Marie was granted 3,461 shares and covered exercise/tax liability with 1,535 shares, increasing direct ownership by 2% to 88,660 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 116d
  President and CEO Basta Steven L was granted 12,362 shares and covered exercise/tax liability with 6,277 shares, increasing direct ownership by 2% to 373,315 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 132d
  Director Parikh Asit gifted 80,500 shares and received a gift of 80,500 shares, decreasing direct ownership by 61% to 50,500 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 136d
  Principal Accounting Officer Breedlove Robert Charles covered exercise/tax liability with 776 shares, decreasing direct ownership by 2% to 47,068 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 144d
  Director Parikh Asit exercised 8,750 shares at a strike of $10.30, increasing direct ownership by 7% to 131,000 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 157d
  President and CEO Basta Steven L was granted 251,034 shares, increasing direct ownership by 221% to 364,820 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 157d
  Chief Legal Off. & Corp. Sec. Cook Anne Marie was granted 75,345 shares, increasing direct ownership by 779% to 85,012 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 157d
  Chief Financial & Bus. Officer Narula Sanjeev was granted 82,715 shares, increasing direct ownership by 57% to 226,715 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 167d
  Director Parikh Asit exercised 8,750 shares at a strike of $10.30, increasing direct ownership by 8% to 122,250 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 171d
  Principal Accounting Officer Breedlove Robert Charles covered exercise/tax liability with 230 shares, decreasing direct ownership by 0.48% to 47,844 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 171d
  Chief Legal Off. & Corp. Sec. Cook Anne Marie covered exercise/tax liability with 7,703 shares and was granted 17,370 shares (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 171d
  President and CEO Basta Steven L covered exercise/tax liability with 31,502 shares and was granted 62,038 shares, increasing direct ownership by 37% to 113,786 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 188d
  President and CEO Basta Steven L covered exercise/tax liability with 48,375 shares and converted options into 90,000 shares, increasing direct ownership by 100% to 83,250 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 215d
  Principal Accounting Officer Breedlove Robert Charles sold $7,079 worth of shares (524 units at $13.51), decreasing direct ownership by 1% to 47,407 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 243d
  Amendment: Chief Financial & Bus. Officer Narula Sanjeev was granted 144,000 shares (SEC Form 4)

  4/A - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 244d
  SEC Form 4 filed by Chief Financial & Bus. Officer Narula Sanjeev

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 255d
  President and CEO Basta Steven L converted options into 90,000 shares and covered exercise/tax liability with 48,375 shares (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 272d
  Principal Accounting Officer Breedlove Robert Charles sold $5,573 worth of shares (461 units at $12.09), decreasing direct ownership by 0.95% to 47,931 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 325d
  Principal Accounting Officer Breedlove Robert Charles sold $14,152 worth of shares (1,692 units at $8.36), decreasing direct ownership by 3% to 48,392 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 349d
  SEC Form 4 filed by Chief Legal Off. & Corp. Sec. Cook Anne Marie

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 368d
  Director Karbe Frank was granted 10,500 shares, increasing direct ownership by 18% to 67,500 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 368d
  Director Cola Michael F was granted 10,500 shares, increasing direct ownership by 36% to 39,798 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 368d
  Director Fields Heidi was granted 10,500 shares, increasing direct ownership by 54% to 30,000 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 368d
  Director Topper James N was granted 10,500 shares, increasing direct ownership by 33% to 42,596 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 368d
  Director Stenhouse Mark was granted 10,500 shares, increasing direct ownership by 54% to 30,000 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 368d
  Director Parikh Asit was granted 10,500 shares, increasing direct ownership by 10% to 113,500 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 383d
  SEC Form 4 filed by Principal Accounting Officer Breedlove Robert Charles

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 418d
  Director Schroeder Theodore R was granted 21,000 shares (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 426d
  CFO and CBO Henderson Molly sold $16,740 worth of shares (3,678 units at $4.55), decreasing direct ownership by 4% to 89,868 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 431d
  SEC Form 4 filed by President and CEO Basta Steven L

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 444d
  Director Parikh Asit exercised 7,500 shares at a strike of $11.72, increasing direct ownership by 9% to 93,000 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 462d
  SEC Form 4 filed by President and Chief Executive Curran Terrie

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 462d
  CFO and CBO Henderson Molly was granted 72,000 shares, increasing direct ownership by 77% to 165,546 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 462d
  Chief Operating Officer Nabulsi Azmi was granted 79,200 shares, increasing direct ownership by 34% to 312,590 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 501d
  CFO and CBO Henderson Molly sold $43,371 worth of shares (6,583 units at $6.59), decreasing direct ownership by 7% to 93,546 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 501d
  Chief Operating Officer Nabulsi Azmi sold $51,957 worth of shares (7,886 units at $6.59), decreasing direct ownership by 3% to 233,390 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 501d
  President and Chief Executive Curran Terrie sold $125,884 worth of shares (19,109 units at $6.59), decreasing direct ownership by 5% to 360,465 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 535d
  Chief Operating Officer Nabulsi Azmi sold $8,944 worth of shares (1,118 units at $8.00), decreasing direct ownership by 0.47% to 239,303 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 535d
  CFO and CBO Henderson Molly sold $10,328 worth of shares (1,291 units at $8.00), decreasing direct ownership by 1% to 98,156 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 691d
  Chief Operating Officer Nabulsi Azmi sold $127,760 worth of shares (10,901 units at $11.72), decreasing direct ownership by 4% to 240,421 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 691d
  CFO and CBO Henderson Molly sold $50,689 worth of shares (4,325 units at $11.72), decreasing direct ownership by 4% to 99,447 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 691d
  President and Chief Executive Curran Terrie sold $396,699 worth of shares (33,848 units at $11.72), decreasing direct ownership by 8% to 377,734 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 738d
  Henderson Molly was granted 7,500 units of Common Stoock, increasing direct ownership by 8% to 102,763 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 738d
  Nabulsi Azmi was granted 7,500 units of Common Stoock, increasing direct ownership by 3% to 249,567 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 738d
  Karbe Frank was granted 25,000 shares, increasing direct ownership by 128% to 44,500 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 745d
  Topper James N was granted 10,500 shares, increasing direct ownership by 49% to 32,096 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 745d
  Parikh Asit was granted 10,500 shares, increasing direct ownership by 19% to 65,500 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 745d
  Cola Michael F was granted 10,500 shares, increasing direct ownership by 56% to 29,298 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 745d
  Fields Heidi was granted 10,500 shares, increasing direct ownership by 117% to 19,500 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)
• 745d
  Karbe Frank was granted 10,500 shares, increasing direct ownership by 117% to 19,500 units (SEC Form 4)

  4 - Phathom Pharmaceuticals, Inc. (0001783183) (Issuer)

Other PHAT categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends